The Stock Market May Be Shifting From Risky Tech Stocks to Safer Sectors. Here Are 3 Stocks to Buy Before They Soar.

Procter & Gamble reported fiscal Q2 revenue of $22.21B vs $22.28B consensus (miss of ~$70M, ~0.3%) but EPS $1.88 vs $1.86 est (beat $0.02), with management calling Q2 the softest quarter. Nice delivered ~<$3.0B revenue (+8% YoY) and operating income +14%, highlighting recurring revenue strength despite AI-sector fatigue. Berkshire Hathaway remains positioned as a defensive play with roughly one-third of market cap tied to wholly owned private cash-generating businesses and ongoing share repurchases under CEO Greg Abel amid a risk-off backdrop driven by Middle East tensions.

Analysis

The market rotation from high-beta AI winners toward capital-light, cash-generative businesses is a multi-month phenomenon, not just a knee-jerk response to geopolitical noise; that favors names with predictable free cash flow and low revenue beta (consumer staples and diversified conglomerates). Second-order: retailers carrying leaner inventories and consumers prioritizing essentials will compress near-term revenue for staples but improve working-capital conversion and margin resilience over 2-4 quarters, setting up outsized free-cash-flow beats versus consensus in H2.

Enterprise AI fatigue has driven indiscriminate selloffs, creating asymmetric opportunities in mission-critical, recurring SaaS (contact-center automation) where switching costs and multi-year contracts mute cyclical capex cuts. For companies with >70% recurring revenue, a 6-12 month elongation of the sales cycle is a liquidity story, not an adoption failure; if cloud migration budgets reallocate toward labor-replacing automation, adoption could accelerate 12–24 months out, producing a re-rate.

Berkshire’s privately held cash engines act as a built-in volatility dampener and a buyback ammunition source that mechanically increases intrinsic per-share economics as repurchases proceed; the transition to new management is the primary behavioral overhang, not cash generation. If repurchases accelerate, expect 1–3% EPS accretion annually from share count reduction and a progressive uplift to NAV multiples over 12 months, especially under sustained risk-off flows.

Key reversals: a swift de-escalation in the Middle East or a fresh upside surprise from leading AI capex names would re-ignite risk-on flows and reverse the defensive bid, compressing staples multiples and lifting AI incumbents within weeks. Watch corporate IT spending surveys and retail inventory-to-sales ratios as 1–3 month leading indicators for whether defensive positioning remains prudent or becomes overdue.

Key Decisions for Investors

• Long PG vs short discretionary consumer (pair): Buy PG shares equal to 1.5% portfolio weight and short DIS or AAL (0.75% weight) to keep net market exposure neutral. Timeframe 6–12 months; objective +10–15% absolute on the long leg if staples multiple re-rating continues, downside ~10% in a severe risk-on snap—pair reduces beta tail risk.
• Long NICE via options (idiosyncratic SaaS re-rate): Purchase Jan-2027 LEAP call calendar (or buy 1–2x equivalent notional of 12–15% OTM LEAPS) sized to 1% of portfolio risk capital. Timeframe 12–24 months; target 2.5x–4x if revenue cadence normalizes and multiples expand, max loss defined as premium (~100% of allocation).
• Overweight BRK-B with market hedge: Buy BRK-B equal to 2% portfolio and hedge systemic exposure by selling an out-of-the-money SPX put spread (30-60 day) funded by the premium. Timeframe 6–12 months; aim to capture 6–12% upside from buybacks/NAV accretion with downside cushioned by short-put premium, but monitor buyback cadence for catalyst confirmation.
• Hedge AI tail-risk: If holding large AI exposure (NVDA/GOOGL), buy a 3-month put spread on an AI-heavy ETF or NVDA to limit drawdown while redeploying capital into NICE/PG. Timeframe 1–3 months; cost should be sized to 0.5–1% portfolio to cap short-term tail losses while maintaining participation in any resumed AI rally.